TC BioPharm (Holdings) plc Warrants
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.025
- Today's High:
- $0.04
- Open Price:
- $0.025
- 52W Low:
- $0.0171
- 52W High:
- $7.5
- Prev. Close:
- $0.04
- Volume:
- 0
Company Statistics
- Market Cap.:
- $0
- Book Value:
- -0.651
- Revenue TTM:
- $1.98 million
- Operating Margin TTM:
- -331.87%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
TC BioPharm (Holdings) plc Warrants had its IPO on 2022-02-11 under the ticker symbol TCBPW.
The company operates in the Healthcare sector and Biotechnology industry. TC BioPharm (Holdings) plc Warrants has a staff strength of 74 employees.
Stock update
Shares of TC BioPharm (Holdings) plc Warrants opened at $0.03 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.03 - $0.04, and closed at $0.04.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of TC BioPharm (Holdings) plc Warrants have increased by 0%.
TC BioPharm (Holdings) plc Warrants's Key Ratios
TC BioPharm (Holdings) plc Warrants has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months TC BioPharm (Holdings) plc Warrants’s revenue was $1.98 million with a gross profit of $0 and an EBITDA of $-5733499. The EBITDA ratio measures TC BioPharm (Holdings) plc Warrants's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, TC BioPharm (Holdings) plc Warrants’s operating margin was -331.87% while its return on assets stood at 0% with a return of equity of 0%.
In Q4, TC BioPharm (Holdings) plc Warrants’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
TC BioPharm (Holdings) plc Warrants’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.754 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into TC BioPharm (Holdings) plc Warrants’s profitability.
TC BioPharm (Holdings) plc Warrants stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
TC BioPharm (Holdings) plc Warrants stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $10.95 million
- Total Liabilities
- $9.16 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $52041
- Dividend Payout Ratio
- 0%
TC BioPharm (Holdings) plc Warrants ended 2024 with $10.95 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.95 million while shareholder equity stood at $-25677.00.
TC BioPharm (Holdings) plc Warrants ended 2024 with $0 in deferred long-term liabilities, $9.16 million in other current liabilities, 397493.00 in common stock, $-33731738.00 in retained earnings and $0 in goodwill. Its cash balance stood at $4.81 million and cash and short-term investments were $4.81 million. The company’s total short-term debt was $981,517 while long-term debt stood at $0.
TC BioPharm (Holdings) plc Warrants’s total current assets stands at $7.45 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.80 million compared to accounts payable of $882364.00 and inventory worth $0.
In 2024, TC BioPharm (Holdings) plc Warrants's operating cash flow was $0 while its capital expenditure stood at $52041.
Comparatively, TC BioPharm (Holdings) plc Warrants paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.04
- 52-Week High
- $7.5
- 52-Week Low
- $0.0171
- Analyst Target Price
- $
TC BioPharm (Holdings) plc Warrants stock is currently trading at $0.04 per share. It touched a 52-week high of $7.5 and a 52-week low of $7.5. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.04 and 200-day moving average was $0.15 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About TC BioPharm (Holdings) plc Warrants
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.